Innovating with in vitro diagnostics
Biosensia operate in the area of in vitro diagnostics (IVD).
The diagnostic market lacks a highly specific and sensitive rapid platform with numerical output and multiplexing capability for the point of care (POC) market.
Biosensia has combined highly innovative technology developments to produce RapiPlex, a practical platform for use in many environments and for multiple IVD applications.
Learn more
Read more about in vitro diagnostics: